Biopharmaceuticals
HIV/AIDS
News Release - September 17, 2007
Schering-Plough Initiates Phase III Studies with Vicriviroc in Treatment- Experienced HIV Patients
Source: Schering-Plough
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.